[3-(1H-imidazol-5-yl)phenyl]amine dihydrochloride hydrate, 95.0%, 5g

2-Cyanopyridine-4-boronic acid pinacol ester, 95.0%, 25g

6-BROMO-5-CYANO-NICOTINIC ACID ETHYL ESTER, 95.0%, 100mg

2-(6,11-Dihydro-5H-benzo[c][1]benzazepin-6-ylmethyl)isoindole-1,3-dione, 97%, 2g

N-(4-Fluoro-3-trifluoromethylphenyl)-2-chloropropanamide, 95%, 2g

4'-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-carbaldehyde, 98%, 1g

1-p-Tolylamino-cyclohexanecarboxylic acid, 95.0%, 10g

2-Methylsulfonyl-1-(4-trifluoromethylphenyl)ethanone, 95.0%, 1g

cycloheptanone oxime, 98.0%, 25g

L-Treonina, 25 g

4-Chloro-7-methoxy-quinoline, 97.0%, 5g

4-Methoxyphenylacetic Acid>98.0%(GC)(T)500g

Recipiente de cristalización DURAN® sin pico, 20 ml, 40 mm, 10 Unidad(es)